Lisinopril and Hydrochlorothiazide

Product NDC
60760-861
11-digit product format
607600861
Labeler code
60760
Product ID
60760-861_bc911eb3-52da-c42d-e053-2995a90a02b4
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Lisinopril and Hydrochlorothiazide
Dosage form
TABLET
Route
ORAL
Labeler
St. Mary's Medical Park Pharmacy
Application
ANDA076194
Marketing category
ANDA
Marketing start
2021-02-24
Marketing end
0000-00-00
Substance
LISINOPRIL; HYDROCHLOROTHIAZIDE
Active strength
20 mg/1; mg/1
Pharmacologic classes
Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
60760-861-90EA - Each60760-861364b14c1-a7bf-437a-86f8-ccd487ffb3b612021-04-08

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
60760-861LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLET [ST. MARY'S MEDICAL PARK PHARMACY]1Legacy NDC20210311_bc912a52-0a1f-c2c1-e053-2995a90ac052.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
60760-861-906076008619090 TABLET in 1 BOTTLE, PLASTIC (60760-861-90) 90 tablet2021-02-240000-00-00NoNoCurrent